Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
IMMP · against 21 other Healthcare companies of similar size
Ranked #4 of 22 · scores higher than 67% of peers
Bars: peers in each 10-point band of the valuation score7 peers with a valuation score of 30–39, including IMMP · Click a bar to see the companies
Mainly because of its earnings yield, which is weaker than most Healthcare peers.
| Metric | IMMP | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 22 reported | Not reported | -103.5% | — | — | 30% |
| EBITDA yieldHigher is better · 26 reported | Not reported | -12.7% | — | — | 50% |
| Free cash flow yieldHigher is better · 14 reported | Not reported | -118.6% | — | — | 20% |
| Book yieldHigher is better · 25 reported | 193.6% | 106.7% | 63% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 272M HKD (≈$35M) | 97 | 59 | |
| 2 | 5.6B JPY (≈$38M) | 88 | 55 | |
| 3 | 3.5B JPY (≈$24M) | 65 | 48 | |
| 4 | 30M USD | 33 | ||
| 4 | 23M USD | 33 | ||
| 4 | 34M USD | 33 | 19 | |
| 4 | 22M USD | 33 | 47 | |
| 4 | 17M USD | 33 | 10 | |
| 9 | 21.3B KRW (≈$15M) | 30 | 28 | |
| 9 | 12M USD | 30 | 38 | |
| 11 | 37M USD | 8 | 21 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score